A Glimpse of Intellia Therapeutics's Earnings Potential
A Glimpse of Intellia Therapeutics's Earnings Potential
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.Intellia Therapeutics (NASDAQ:NTLA) is gearing up to announce its quarterly earnings on Thursday, 2024-11-07. Here's a quick overview of what investors should know before the release.
Intellia Therapeutics（納斯達克：NTLA）正準備在2024年11月7日星期四公佈季度業績。在發佈之前，投資者應該了解的一些重要信息如下。
Analysts are estimating that Intellia Therapeutics will report an earnings per share (EPS) of $-1.38.
分析師預計Intellia Therapeutics的每股收益（EPS）將爲-1.38美元。
Investors in Intellia Therapeutics are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
Intellia Therapeutics的投資者正急切等待公司的公告，希望能獲得超出預期的消息，並獲得下一季度的積極指引。
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
值得新投資者注意的是，股票價格往往受未來預期的影響，而不僅僅是過去的業績。
Performance in Previous Earnings
Performance in Previous Earnings
In the previous earnings release, the company missed EPS by $0.29, leading to a 4.11% drop in the share price the following trading session.
在上一次的業績發佈中，該公司的EPS不及0.29美元，導致隨後交易日股價下跌了4.11%。
Here's a look at Intellia Therapeutics's past performance and the resulting price change:
讓我們回顧一下Intellia Therapeutics過去的表現和由此產生的價格變動：
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -1.23 | -1.38 | -1.45 | -1.50 |
| EPS Actual | -1.52 | -1.12 | -1.46 | -1.38 |
| Price Change % | -4.0% | -2.0% | -4.0% | -3.0% |
| 季度 | 2024年第二季度 | Q1 2024 | 2023年第四季度 | 2023年第三季度 |
|---|---|---|---|---|
| 每股收益預估值 | -1.23 | -1.38 | -1.45 | -1.50 |
| 每股收益實際值 | -1.52 | -1.12 | -1.46 | -1.38 |
| 價格變更% | -4.0% | -2.0% | -4.0% | -3.0% |
Stock Performance
股票表現
Shares of Intellia Therapeutics were trading at $15.43 as of November 05. Over the last 52-week period, shares are down 37.16%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.
Intellia Therapeutics股票截至11月05日報價爲15.43美元。在過去的52周內，股價下跌了37.16%。鑑於這些回報通常爲負，長期股東可能在此業績發佈前感到不滿。
To track all earnings releases for Intellia Therapeutics visit their earnings calendar on our site.
要追蹤Intellia Therapeutics的所有業績，請訪問我們網站上的業績日曆。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文是由Benzinga的自動內容引擎生成，並由編輯審核。
譯文內容由第三人軟體翻譯。
